Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1

Conditions

Sarcoma 4Sarcoma, Ewing 3Osteosarcoma 3Liposarcoma 3Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrence 1Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Leiomyosarcoma 1Hemangiosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colonic Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Ifosfamide 5Filgrastim 5Doxorubicin 5Gemcitabine 4Docetaxel 4Radiotherapy 3Proton Therapy 3Carboplatin 3regorafenib 2ivosidenib 2enasidenib 2belinostat 2Sunitinib 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Immune Checkpoint Inhibitors 2HhAntag691 2Fluorouracil 2Etoposide 2Epirubicin 2Cyclophosphamide 2Cisplatin 2Chemotherapy, Adjuvant 2Celecoxib 2Bevacizumab 2venetoclax 1toripalimab 1temsirolimus 1tazemetostat 1tanespimycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × abemaciclib × Sarcoma × Clear all
NCT04040205 2025-07-20

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Medical College of Wisconsin

Phase 2 Recruiting
44 enrolled
Other solid neoplasmSarcoma

Chondrosarcoma, Retinoblastoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡